Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities
Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities
复制标题
DOI：
10.1086/499951
复制
发表时间：
2006-03-01
影响因子：
11.8
通讯作者：
Strathdee, SA
中科院分区：
文献类型：
--
作者：
Hagan, H;Latka, MH;Strathdee, SA
在404名年龄在18-35岁、丙型肝炎病毒核糖核酸检测呈阳性的注射吸毒者中，96%的人患有可能不适合丙型肝炎治疗的禁忌症(例如，问题饮酒、中度至重度抑郁症和最近注射的药物)。限制性的资格标准可能会拒绝对很大一部分可能从中受益的患者进行治疗。
Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment ( e. g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.